The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL...

por Witzens-Harig, Mathias, Viardot, Andreas, Keller, Ulrich, Wosniok, Julia, Deuster, Oliver, Klemmer, Jennifer, Geueke, Anne-Marie, Meißner, Julia, Ho, Anthony D., Atta, Johannes, Marks, Reinhard, La Rosée, Paul, Buske, Christian, Dreyling, Martin H., Hess, Georg
Publicado 2021